RISPERIDEX 3 MG

Țară: Israel

Limbă: engleză

Sursă: Ministry of Health

Ingredient activ:

RISPERIDONE

Disponibil de la:

DEXCEL PHARMA TECHNOLOGIES LTD

Codul ATC:

N05AX08

Forma farmaceutică:

TABLETS

Compoziție:

RISPERIDONE 3 MG

Calea de administrare:

PER OS

Tip de prescriptie medicala:

Required

Produs de:

DEXCEL LTD, ISRAEL

Grupul Terapeutică:

RISPERIDONE

Zonă Terapeutică:

RISPERIDONE

Indicații terapeutice:

Risperidone is indicated for the management of schizophrenia and manifestation of psychotic disorders. The antipsychotic efficacy of Risperidone was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. Risperidone is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.Risperidone is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe Alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. Conduct and other disruptive disorders: Treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. Treatment should not be given to children under the age of 5 years.Risperidone is indicated for the treatment of mania in bipolar disorder. These episodes are characterized by symptoms such as elevated, expansive or irritable mood, inflated self-esteem, decreased need for sleep, pressured speech, racing thoughts, distractibility, or poor judgment, including disruptive or aggressive behaviors

Data de autorizare:

2021-05-31